title: Controversies and role of HPV16 in recurrent/metastatic squamous cell cancers of the head and neck.
authors.affiliation: Department of Medicine, Division of Hematology and Medical Oncology, The Tisch Cancer Institute at Mount Sinai Hospital, New York krzysztof.misiukiewicz@mssm.edu.
authors.forename: K
authors.initials: K
authors.lastname: Misiukiewicz
authors.affiliation: Department of Medicine, Division of Hematology and Medical Oncology, Wake Forest Baptist Medical Center, Winston-Salem.
authors.forename: M
authors.initials: M
authors.lastname: Bonomi
authors.affiliation: Department of Pathology, Mount Sinai Hospital, New York, USA.
authors.forename: E
authors.initials: E
authors.lastname: Demicco
authors.affiliation: Department of Medicine, Division of Hematology and Medical Oncology, The Tisch Cancer Institute at Mount Sinai Hospital, New York.
authors.forename: M
authors.initials: M
authors.lastname: Posner
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002294:Carcinoma, Squamous Cell / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology* / Q000821:virology*; D000068818:Cetuximab; D034462:Dissent and Disputes; D006258:Head and Neck Neoplasms / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology* / Q000821:virology*; D052162:Human papillomavirus 16 / Q000502:physiology*; D006801:Humans; D009362:Neoplasm Metastasis; D000077544:Panitumumab; D030361:Papillomavirus Infections / Q000150:complications*; D011379:Prognosis; D012008:Recurrence; D000077195:Squamous Cell Carcinoma of Head and Neck
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000077544:Panitumumab; D000068818:Cetuximab